Proteomics

Dataset Information

0

Quantitative timecourse analysis of oncogenic KRAS expression impact on the proteme of pancreatic ductal adenocarcinoma cells.


ABSTRACT: To reveal the impact of mutant KRAS expression on the proteome of Pancreatic Ductal Adenocarcinoma (PDAC) cells, we carried out a timecourse quantitative proteomic analysis of tumour cells isolated from an inducible mouse model of PDAC (iKras PDAC) (Ying et al., 2012). In this model, oncogenic Kras (G12D) expression can be controlled by administration of doxycycline(Dox). Cells were grown in the absence of Dox for 48 hrs, before being treated with or without Dox for 4, 8, 12, 24, and 36 hrs, followed by total lysis and quantitative proteomics analysis using Tandem Mass Tagging (TMT). A total of 2 biological replicate experiments were analysed, with all samples from each replicate barcoded and pooled together using TMT 10plex labelling kit (Thermo).

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Permanent Cell Line Cell, Cell Culture

DISEASE(S): Carcinoma

SUBMITTER: Faraz Mardakheh  

LAB HEAD: Faraz K. Mardakheh

PROVIDER: PXD038440 | Pride | 2023-02-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
QE2_20200805_1_F1.raw Raw
QE2_20200805_1_F2.raw Raw
QE2_20200805_1_F3.raw Raw
QE2_20200805_1_F4.raw Raw
QE2_20200805_1_F5.raw Raw
Items per page:
1 - 5 of 21

Similar Datasets

2023-02-12 | PXD038441 | Pride
2023-02-12 | PXD038439 | Pride
2023-02-12 | PXD038338 | Pride
2023-02-12 | PXD030893 | Pride
2023-02-12 | PXD038496 | Pride
2020-10-20 | PXD021180 | Pride
2023-02-12 | PXD030825 | Pride
2020-10-20 | PXD021239 | Pride
2020-10-20 | PXD021203 | Pride
2020-10-20 | PXD021206 | Pride